Daily Record of Severity of Problems (DRSP): reliability and validity

  title={Daily Record of Severity of Problems (DRSP): reliability and validity},
  author={Jean Endicott and John Nee and Wilma Harrison},
  journal={Archives of Women's Mental Health},
SummaryThe Daily Record of Severity of Problems (DRSP) form was developed to aid in the diagnosis and evaluation of DSM-IV Premenstrual Dysphoric Disorder (PMDD). The reliability and validity of the procedure was tested in two studies. Study A included 27 subjects who ranged from having few or no premenstrual problems to those who met criteria for PMDD. Study B included 243 subjects, all of whom met criteria for PMDD. Individual items and Summary Scores had high test–retest reliability in both… 
Using the Daily Record of Severity of Problems as a Screening Instrument for Premenstrual Syndrome
The DRSP administered on the first day of menses is an acceptable screening instrument to identify women who may have premenstrual syndrome who should undergo further evaluation.
Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).
The Carolina Premenstrual Assessment Scoring System is a reliable and valid companion protocol to the DRSP that standardizes and streamlines the complex, multilevel diagnosis of DSM-5 PMDD.
Chinese version of Daily Record of Severity of Problems: reliability and validity.
The Daily Record of Severity of Problems Chinese version provides reliable and valid measures of premenstrual symptoms in Chinese women and has satisfactory psychometric properties and is suitable for nursing implication.
Premenstrual Syndrome Diagnosis: A Comparative Study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST).
  • Aline Henz, C. Ferreira, M. C. Wender
  • Medicine
    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
  • 2018
The PSST should be considered a diagnostic screening tool for premenstrual symptoms screening tool and positive PMS/PMDD cases by PS ST should be further evaluated by DRSP to confirm the diagnosis.
Psychometric Properties of a DSM-5-Based Screening Tool for Women's Perceptions of Premenstrual Symptoms
Initial evidence for the reliability and construct validity of this symptom screening measure suggests potential value for assessing premenstrual symptomatology in research and practice.
Explorative Evaluation of the Impact of Premenstrual Disorder on Daily Functioning and Quality of Life
Moderate-to-severe PMS/PMDD has a negative impact on HR-QOL, hobbies and social activities, and relationships with others.
Daily symptom ratings for studying premenstrual dysphoric disorder: A review.
Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity.
A DSM-5-based tool to monitor concurrent mood and premenstrual symptoms: the McMaster Premenstrual and Mood Symptom Scale (MAC-PMSS)
A new DSM-5-based questionnaire to prospectively monitor concurrent premenstrual and mood symptoms in women with mood disorders is developed, and the MAC-PMSS is a reliable to tool to measure concurrent mood and pre menstrual symptoms.
Diagnosing premenstrual dysphoric disorder: the reliability of a structured clinical interview
The reliability of a Structured Clinical Interview for DSM-IV-TR-Defined PMDD (SCID-PMDD) was assessed with 96 participants who spanned the full range of premenstrual problems.


Reliability and validity of a daily diary for premenstrual syndrome
The measurement of premenstrual mood symptoms.
Premenstrual syndrome: evidence for symptom stability across cycles.
It is concluded that PMS is a stable syndrome that may best be viewed as part of the spectrum of recurrent mood disorders, and three mood symptoms were the most stable symptoms in this group of women with PMS.
  • M. Hamilton
  • Psychology, Medicine
    Journal of neurology, neurosurgery, and psychiatry
  • 1960
The present scale has been devised for use only on patients already diagnosed as suffering from affective disorder of depressive type, used for quantifying the results of an interview, and its value depends entirely on the skill of the interviewer in eliciting the necessary information.
Predictors of response to sertraline treatment of severe premenstrual syndromes.
Baseline post menstrual symptom ratings controlled for baseline premenstrual symptoms were associated with PMS symptoms at sertraline treatment endpoint and the findings suggest that nonMenstrual-related baseline characteristics other than depression may influence sertRALine treatment outcome in patients with higher postmenstruals symptom levels.
Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.
The findings suggest that the Q-LES-Q measures may be sensitive to important differences among depressed patients that are not detected by the measures usually employed.
Symptomatic Improvement of Premenstrual Dysphoric Disorder With Sertraline Treatment: A Randomized Controlled Trial
Serotonin reuptake inhibitors such as sertraline are useful therapeutic options for women with premenstrual dysphoria as reflected by symptomatic improvement and change in reported functional impairment.
Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
Serotonin reuptake inhibitors such as sertraline are useful therapeutic options for women with premenstrual dysphoria as reflected by symptomatic improvement and change in reported functional impairment.
Quantification of agreement in psychiatric diagnosis. A new approach.
As generally used, all of the methods used for quantifying the salient features of the data suffer from one or more deficiencies which are illustrated using the hypothetical data of Table 1.
Clinical significance of premenstrual dysphoric changes.
The authors discuss the possible influence of menstrual cycle phases on the evaluation and treatment of women by investigators and therapists and the increased likelihood of suicidal, aggressive, or impulsive behavior during the premenstrual period.